higher as a consequence as community pharmacists, unlike their hospital based colleagues, cannot usually buy in bulk when they are only rarely dispensing certain drugs. Nor do they have the preferential pricing advantage offered to their hospital colleagues. The motivation to shift prescribing costs from hospitals to general practice would be reduced if the relevant health authorities-that is, the district health authorities and the family health services authorities held a common drug budget or if virement between drug and other budgets in hospitals was disallowed.
There are also possible adverse implications for patient care. General practitioners may lack the knowledge and, in some cases, the technical resources needed to monitor the dosage, side effects, and response of patients to specialist hospital drug regimens. They do not have access to the skill of the ward pharmacist, a service available to the hospital doctor.
Patients may find it difficult to arrange at short notice for their general practitioner to continue their hospital initiated drug treatments. In addition, they may find that they have to pay for two prescriptions when one is sufficient.
There are also possible advantages. The savings made by hospitals in their drug budgets could be used to increase the numbers of patients treated and the range of services offered. Transferring prescribing responsibility to general practitioners may reduce the confusion which can arise from having two prescribers (that is, the general practitioner and the consultant) for one patient and should help to clarify which doctor bears the clinical responsibility. Patients may prefer to obtain their prescription from the community pharmacist for reasons of accessibility, the convenience, hours of opening, and availability of non-pharmaceutical products.
The current trend towards more restrictive outpatient dispensing may have both beneficial and negative effects on the quality of outpatient care. In subsequent papers we examine the opinions of general practitioners, hospital consultants, and hospital and community pharmacists about the implications of current hospital outpatient dispensing policies.
We thank particularly the chief pharmacists of all the hospitals who participated in the study, and Linda MacraeSamuel, Frances Smyth, and Mary Taylor for their valuable help with research. The study was funded by a grant from the Department of Health. 
Introduction
The two level health care system in Britain relies on general practitioners referring patients to hospital based specialists who advise on appropriate treatment and, when necessary, undertake treatment. The decision as to which doctor is best able to assume clinical responsibility, and therefore responsibility for prescribing, should be negotiated between the individuals concerned. Recently, however, concern has been expressed that prescribing at the hospitalgeneral practice interface may have become governed by considerations of cost and available resources rather than professional considerations. '4 Cash limited hospitals can save funds by shifting outpatient prescribing costs on to general practitioners. The concern expressed by general practitioners is likely to be increased now that there are indicative prescribing allowances in general practice and even tighter controls on hospital budgets through contracts.56 In an accompanying paper we suggested that the supply of drugs given to outpatients was being further restricted. We compared the responses in the postal questionnaires with those in the telephone interviews to assess the possible bias introduced by this change in data collection. There was good agreement for the proportions of doctors who had been asked to prescribe specialist hospital treatments, the proportions who had objected to this, and the nature of their objections. We concluded that no major bias had been introduced, and the final analysis was carried out on the combined data.
Overall, 570 (46%) general practitioners said that they had been asked by the hospital to prescribe drugs for which they felt unable to take clinical responsibility, such as fertility treatments, growth hormone, anticancer treatments (immunosuppressants and cytotoxic drugs), and drugs used in renal failure (fluid for continuous ambulatory peritoneal dialysis and erythropoietin). When general practitioners were asked why they felt unable to take clinical responsibility for these drugs the principal reasons they endorsed from a list of possibilities were difficulty in detecting side effects, uncertainty about explaining treatment to patients, difficulty monitoring dosage, high cost of drug, and lack of knowledge about the treatment ( 33 (7) responsibility for outpatients the procedures they most 18 (4) commonly endorsed from a list of possibilities were the 12 (3) same as those given by general practitioners (table IV) .
Iity: There were no significant differences among the Our findings need to be considered within the overall limitations of the study. The general practitioners and consultants selected for investigation are not representative of the country as a whole as they practised near or in one of 94 major acute hospitals, which in turn had been selected to include a disproportionate number of teaching hospitals and those with either very restrictive or very liberal outpatient dispensing policies. We assumed that general practitioners would refer most of their patients to these hospitals. However, they reported referring patients to a wide number of hospitals and did not respond to our questionnaire solely in relation to the selected hospital. Our data are likely, therefore, to underestimate the BMJ VOLUME 304 4 JANUARY 1992true strength of the associations between the selected hospital's outpatient dispensing policy and the general practitioners views.
Consultants were drawn from eight medical specialties likely to experience prescribing problems in their interface with general practice and are not necessarily representative of consultants generally. In addition, as consultants in most hospitals were exempt from certain outpatient dispensing restrictions their experience does not reflect that of more junior medical staff, who receive no such exemption. An added limitation is that consultants were recruited to the study by hospital chief pharmacists, who may have preferentially selected those whom they thought would respond or whose views were similar to their own. This bias is offset by the fact that many hospitals have only one consultant in a given speciality, offering no scope for selection.
The response rates among general practitioners (64%) and consultants (63%) were not high, introducing the possibility of non-responder bias. Doctors with particular problems with hospital outpatient dispensing may be overrepresented in our sample. Nevertheless, if we were to assume that all non-responders had no problems with hospital outpatient dispensing policies the proportions who were dissatisfied would still be considerable. Among general practitioners there would remain a third who felt unable to take clinical responsibility, for certain drug treatments initiated by the hospital and halfwho had been asked at least monthly to complete a short course of treatment initiated by the hospital. Among consultants there would remain more than a third who found it necessary to circumvent the hospital's restrictions by asking the general practitioner to prescribe and half who wished to retain responsibility for prescribing certain drug treatments.
IMPACT OF POLICY
Nearly halfof the general practitioners surveyed said that they had been asked by the hospital to prescribe drugs for which they felt unable to take clinical responsibility. General practitioners said that they lacked the knowledge and, in some instances, the technical resources needed to monitor drug dosage, side effects, and response to treatment. It could be argued that these aspects of patient care might be "shared" with the hospital doctor, who has the necessary expertise and resources. General practitioners, however, voiced strong objections to prescribing a drug treatment when they had no other clinical responsibility for the management of that aspect of the patient's condition. Consultants' views complemented those of general practitioners. Nearly three quarters of consultants wished to retain responsibility when there was a specialist need to initiate, stabilise, or monitor drug treatment.
Infertility drugs were the treatments with which general practitioners most often had difficulty. General practitioners volunteered that it was not appropriate that they should assume prescribing responsibility when treatment effects could not adequately be monitored in general practice, particularly as they would share legal liability for possible adverse outcomes such as multiple pregnancy. Some hospitals have considered offering a legal waiver that would release general practitioners from the clinical responsibility of agreeing to prescribe certain specialist drugs.8 At present, however, there is no legal precedent for clinical responsibility to be dissociated from responsibility for prescribing.9
Improved communication between general practitioners and consultants was seen by both groups as a stratagem for ameliorating prescribing problems at the hospital-general practice interface. Most doctors in both groups endorsed the view that general practitioners should make clear in their letter of referral whether consultants should treat or only advise about treatment and that consultants should communicate promptly with general practitioners, explaining the proposed course of treatment. These suggestions amount to making an explicit agreement as to which doctor has clinical responsibility for which elements of the patient's care at any given time. If clinical responsibility carries with it the responsibility for prescribing such agreements would make clear who should write the drug prescription. Flexibility is essential as there was considerable variation among general practitioners in the drugs for which they felt unable to assume responsibility and among consultants in the drugs for which they wished to retain responsibility.
Restrictive hospital outpatient dispensing policies were seen as preventing general practitioners and consultants from implementing agreements which they would otherwise prefer. We found that the more restricted the supply of drugs given to outpatients the more frequently the consultant circumvented the restrictions by asking general practitioners to prescribe and the more likely general practitioners were to be asked to complete a short course of treatment initiated by the hospital. The respondents also volunteered that restrictive policies increased the workload of general practitioners, were inconvenient for patients, and added to overall NHS costs as many specialist drugs were more highly priced when dispensed in the community.
There was widespread concern that restrictions on the nature and quantities of drugs supplied to outpatients were intended mainly to save money, a strategy which served to shift clinical responsibility on to general practitioners, who were not always best able to assume such responsibility. General practitioners and consultants agreed that hospital doctors should be able to retain clinical responsibility, including that for prescribing, when they judged it was appropriate. If guidelines on prescribing at the hospital-general practice interface are to prove effective and beneficial they must address this central issue of which doctor is best able to assume clinical responsibility at any given time. Patients' views need to be sought about the implications of the provisions made for outpatient care in terms of their health, convenience, and personal cost.
